Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Imad Ahmad Mahmoud Nasser, M.B.,B.S.

Co-Author

This page shows the publications co-authored by Imad Nasser and Michelle Lai.
Connection Strength

0.905
  1. Differential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLD. Hepatol Commun. 2020 May; 4(5):670-680.
    View in: PubMed
    Score: 0.216
  2. A Pathophysiologic Approach Combining Genetics and Insulin Resistance to Predict the Severity of Nonalcoholic Fatty Liver Disease. Hepatol Commun. 2018 Dec; 2(12):1467-1478.
    View in: PubMed
    Score: 0.196
  3. The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease. Am J Gastroenterol. 2016 05; 111(5):677-84.
    View in: PubMed
    Score: 0.164
  4. Poor Inter-test Reliability Between CK18 Kits as a Biomarker of NASH. Dig Dis Sci. 2016 Mar; 61(3):905-12.
    View in: PubMed
    Score: 0.159
  5. The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol. 2007 Dec; 47(6):760-7.
    View in: PubMed
    Score: 0.091
  6. Quantitative digital pathology reveals association of cell-specific PNPLA3 transcription with NAFLD disease activity. JHEP Rep. 2019 Sep; 1(3):199-202.
    View in: PubMed
    Score: 0.051
  7. Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis. J Gastroenterol Hepatol. 2010 Sep; 25(9):1562-8.
    View in: PubMed
    Score: 0.028
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.